Role of Biomarkers in Individualizing Treatment Selection for Patients with Cancer
Biomarker testing is increasingly being utilized to match patients with appropriate therapies.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Role of Biosimilars in the Oncology Ecosystem
While biosimilars and generics are not the same, biosimilars are very likely to adopt the same role in the market over the next decade; however, their safety, efficacy, and general role in the clinical setting remains unclear.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Implementing Clinical Trials in the Community Setting
Many community practices do not have the necessary resources and expertise to offer clinical trials to patients, which limits access in remote areas.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Key Considerations in Adopting a Value-Based Payment Model
The shift from fee-for-service to value is well underway; there are at least 20 payment reform models currently in existence or proposed for adoption, from payers and/or physician groups.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation